{
  "retracted": false,
  "timestamp": 1417478400000,
  "updates": [
    {
      "timestamp": 1559040192567,
      "identifier": {
        "doi": "10.1007/s00280-014-2625-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-014-2609-3"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer"
}
